Upstate Active Clinical Trials
Study Title:AMG 592 - A Phase 2b Dose Ranging Study to Evaluate the Efficacy and Safety of Efavaleukin Alfa in Subjects with Active Systemic Lupus Erythematosus with Inadequate Response to Standard of Care Therapy 20200234
Upstate Institutional Review Board (IRB) Number:1746887
Patient Age Group:Adults
Principal Investigator:Andras Perl, MD, PhD
Who can I contact for more information?
Name: Joanne M Chilton, CCRP